-
A restructuring of the Medicare drug benefit has wiped out big drug bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
-
The FDA said Florida’s program will be authorized for two years. Approval comes after months of wrangling that led to the state filing two lawsuits against the agency.
-
Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.
-
John Kapoor, the former billionaire who founded drugmaker Insys Therapeutics, is among the executives to be sentenced for racketeering.
-
There are many moving parts in the nation’s ongoing health care debate. One of the most embattled at the moment is the pharmaceutical industry. Now...